• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. ADVIA CENTAUR CP TOTAL HCG (THCG) ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC. ADVIA CENTAUR CP TOTAL HCG (THCG) ASSAY Back to Search Results
Model Number N/A
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/09/2023
Event Type  malfunction  
Manufacturer Narrative
The customer from (b)(6) obtained a discordant elevated advia centaur cp - total hcg (thcg) result for one female patient sample.The initial result was reported to the physician, who questioned the result.The sample was repeated on the same advia centaur system, and the result was lower.The interpretation of results section of the advia centaur cp total hcg instructions for use states: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings." siemens continues to investigate.
 
Event Description
The customer obtained a discordant elevated advia centaur cp - total hcg (thcg) result for one female patient sample.The initial result was reported to the physician, who questioned the results.The sample was repeated on the same advia centaur system, and the result was lower.There are no reports that treatment was altered or prescribed or adverse health consequences due to the discordant advia centaur cp total hcg result.
 
Manufacturer Narrative
Initial mdr 1219913-2023-00049 was filed on march 15, 2023 reporting a customer from united states obtained a discordant elevated advia centaur cp - total hcg (thcg) result for one female patient sample.The initial result was reported to the physician, who questioned the result.The sample was repeated on the same advia centaur cp system, and the result was lower.Additional information on march 22, 2023: service replaced the reagent syringe on (b)(6) 2023.The customer had no further concerns with the instrument or thcg performance since service.No further support is required.Additional information on march 24, 2023: the customer reported a falsely elevated discordant patient result on advia centaur cp total hcg (thcg) reagent lot 345.On (b)(6) 2023, a patient resulted as 570 miu/ml which was questioned by the physician.The same sample was repeated and resulted as <5 miu/ml.The lower repeat value was issued with a corrected report.The calibration of thcg reagent lot 345 was valid and biorad quality control (qc) lots 40400 and 42293 recovered within range on the day of this event.The customer pulled thcg samples that ran before and after the discordant sample and all three of those samples repeated similar to the initial result.Service was dispatched and learned that on (b)(6) 2023 the operators cleaned up a substantial amount of a liquid substance from the top of the incubation ring cover.There was evidence of a spill, and it is possible a few of cuvettes were contaminated in the vicinity of the liquid.The service engineer suspected that the liquid could have come from the reagent syringe assembly so it was replaced.Following service thcg was recalibrated, quality control (qc) was in range and no leaks have been identified.The customer is operational and requires no further support.No potential product issue is observed.The customer is operational.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR CP TOTAL HCG (THCG) ASSAY
Type of Device
TOTAL HCG (THCG) ASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC
333 coney street
east walpole MA 02032
Manufacturer Contact
louise mclaughlin
333 coney street
east walpole, MA 02032
7818564812
MDR Report Key16543951
MDR Text Key311381322
Report Number1219913-2023-00049
Device Sequence Number1
Product Code JHI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K925277
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/15/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/13/2023
Device Model NumberN/A
Device Catalogue Number10308985
Device Lot Number345
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/22/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/13/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age36 YR
Patient SexFemale
-
-